Neoadjuvant Chemotherapy with Capecitabine and Temozolomide for Unresectable Pancreatic Neuroendocrine Tumor
Pancreatic neuroendocrine tumors (PNETs) are relatively rare tumors that arise in the endocrine cells of the pancreas. Historically, somatostatin analogues have been used in this disease primarily for symptom control and, to a limited extent, disease stability. More recently, sunitinib and everolimu...
| Main Authors: | , |
|---|---|
| Format: | Online |
| Language: | English |
| Published: |
S. Karger AG
2012
|
| Online Access: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3531952/ |